SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-033592
Filing Date
2022-06-17
Accepted
2022-06-17 16:05:44
Documents
16
Period of Report
2022-06-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161716-8k_moonlake.htm   iXBRL 8-K 32169
2 LETTER FROM WITHUMSMITH+BROWN, PC ADDRESSED TO THE SECURITIES AND EXCHANGE COMMI ea161716ex16-1_moonlake.htm EX-16.1 3023
6 GRAPHIC ex16-1_001.jpg GRAPHIC 10032
7 GRAPHIC ex16-1_002.jpg GRAPHIC 5977
8 GRAPHIC ex16-1_003.jpg GRAPHIC 18499
  Complete submission text file 0001213900-22-033592.txt   259606

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mltx-20220615.xsd EX-101.SCH 3039
4 XBRL LABEL FILE mltx-20220615_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE mltx-20220615_pre.xml EX-101.PRE 22599
10 EXTRACTED XBRL INSTANCE DOCUMENT ea161716-8k_moonlake_htm.xml XML 3606
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 221023773
SIC: 2834 Pharmaceutical Preparations